Shakeel Modak

Shakeel Modak

UNVERIFIED PROFILE

Are you Shakeel Modak?   Register this Author

Register author
Shakeel Modak

Shakeel Modak

Publications by authors named "Shakeel Modak"

Are you Shakeel Modak?   Register this Author

98Publications

1625Reads

20Profile Views

Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma.

Pediatr Blood Cancer 2019 Nov 12;66(11):e27960. Epub 2019 Aug 12.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27960DOI Listing
November 2019

Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving Chemotherapy.

J Pediatr Hematol Oncol 2019 May;41(4):e257-e259

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000001187DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195864PMC
May 2019

Treatment and outcome of adult-onset neuroblastoma.

Int J Cancer 2018 09 6;143(5):1249-1258. Epub 2018 Apr 6.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103828PMC
September 2018

Dose-escalation is needed for gross disease in high-risk neuroblastoma.

Pediatr Blood Cancer 2018 07 22;65(7):e27009. Epub 2018 Feb 22.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, New York.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.27009
Publisher Site
http://dx.doi.org/10.1002/pbc.27009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625659PMC
July 2018

Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?

Int J Radiat Oncol Biol Phys 2018 04 9;100(5):1204-1209. Epub 2018 Jan 9.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2018.01.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934297PMC
April 2018

Failure of MIBG scan to detect metastases in SDHB-mutated pediatric metastatic pheochromocytoma.

Pediatr Blood Cancer 2017 Nov 14;64(11). Epub 2017 Apr 14.

Department of Pediatrics, Memorial Sloan Kettering Cancer Centre, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26549DOI Listing
November 2017

-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G immunotherapy.

Oncotarget 2017 Nov 24;8(56):95293-95302. Epub 2017 Aug 24.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20513DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707022PMC
November 2017

Epigenetic Combination Therapy for Children With Secondary Myelodysplastic Syndrome (MDS)/Acute Myeloid Leukemia (AML) and Concurrent Solid Tumor Relapse.

J Pediatr Hematol Oncol 2017 10;39(7):560-564

*Department of Pediatric Hematology/Oncology, Winthrop University Medical Center, Mineola †Department of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Medical Center, New York Presbyterian Hospital §Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY ‡Department of Pediatric Hematology/Oncology, Arnold Palmer Hospital for Children, Orlando, FL.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00043426-201710000-0001
Publisher Site
http://dx.doi.org/10.1097/MPH.0000000000000868DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708164PMC
October 2017

Long-term Pulmonary Outcomes in Pediatric Survivors of High-risk Neuroblastoma.

J Pediatr Hematol Oncol 2017 10;39(7):547-554

*Department of Pediatrics, Division of Pulmonology, Allergy and Immunology, Weill Cornell Medical College ∥Department of Healthcare Policy and Research, Division of Biostatistics and Epidemiology, Weill Cornell Medical College Departments of †Pediatrics ‡Radiation Oncology §Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663196PMC
October 2017

Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy: 123I-MIBG Versus Posttherapy 131I-MIBG Imaging.

Clin Nucl Med 2017 Oct;42(10):741-748

From the *Molecular Imaging and Therapy Service, Department of Radiology, and Departments of †Medical Physics, ‡Epidemiology and Biostatistics, and §Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753751PMC
October 2017

Anti-GD2 immunotherapy for neuroblastoma.

Expert Rev Anticancer Ther 2017 10 14;17(10):889-904. Epub 2017 Aug 14.

a Department of Pediatrics , Memorial Sloan Kettering Cancer Center , New York , NY , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2017.1364995DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082365PMC
October 2017

Renal Function Outcomes of High-risk Neuroblastoma Patients Undergoing Radiation Therapy.

Int J Radiat Oncol Biol Phys 2017 10 11;99(2):486-493. Epub 2017 Apr 11.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.04.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674789PMC
October 2017

Norepinephrine Transporter as a Target for Imaging and Therapy.

J Nucl Med 2017 09;58(Suppl 2):39S-53S

Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://jnm.snmjournals.org/lookup/doi/10.2967/jnumed.116.186
Publisher Site
http://dx.doi.org/10.2967/jnumed.116.186833DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577620PMC
September 2017

Combination of bevacizumab, irinotecan, and temozolomide for refractory or relapsed neuroblastoma: Results of a phase II study.

Pediatr Blood Cancer 2017 08 23;64(8). Epub 2017 Jan 23.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.26448
Publisher Site
http://dx.doi.org/10.1002/pbc.26448DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5555116PMC
August 2017

A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.

Pediatr Blood Cancer 2017 Jul 30;64(7). Epub 2016 Dec 30.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26409DOI Listing
July 2017

Acute myeloid leukemia therapy elicits durable complete response in chemoradio-resistant metastatic paraganglioma.

Pediatr Blood Cancer 2017 05 2;64(5). Epub 2016 Nov 2.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.26314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535780PMC
May 2017

Is Extended Sedation Necessary for Young Children Receiving High-Dose (131) I-MIBG Therapy?

Pediatr Blood Cancer 2016 10 16;63(10):1867. Epub 2016 May 16.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.26070
Publisher Site
http://dx.doi.org/10.1002/pbc.26070DOI Listing
October 2016

Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma.

Int J Radiat Oncol Biol Phys 2016 10 27;96(2):393-400. Epub 2016 May 27.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2016.05.020DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5476959PMC
October 2016

Management of desmoplastic small round cell tumor.

Semin Pediatr Surg 2016 Oct 14;25(5):299-304. Epub 2016 Sep 14.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.sempedsurg.2016.09.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614508PMC
October 2016

Desmoplastic small round cell tumor 20 years after its discovery.

Future Oncol 2015 ;11(7):1071-81

Department of Pediatric Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.32DOI Listing
February 2016

Salvage rates after progression of high-risk neuroblastoma with a soft tissue mass.

J Pediatr Surg 2016 Feb 5;51(2):285-8. Epub 2015 Nov 5.

Pediatric Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2015.10.075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769938PMC
February 2016

Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.

J Nucl Med 2016 Feb 7;57(2):231-7. Epub 2016 Jan 7.

Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.115.161752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976822PMC
February 2016

Trametinib-induced Left Ventricular Dysfunction in a Child With Relapsed Neuroblastoma.

J Pediatr Hematol Oncol 2015 Aug;37(6):e381-3

*Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY Divisions of †Cardiology ‡Hematology-Oncology, All Children's Hospital, St Petersburg, FL.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000364DOI Listing
August 2015

Osteochondroma in long-term survivors of high-risk neuroblastoma.

Cancer 2015 Jun 27;121(12):2090-6. Epub 2015 Feb 27.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.29316
Publisher Site
http://dx.doi.org/10.1002/cncr.29316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970322PMC
June 2015

When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?

J Clin Oncol 2014 Dec 17;32(36):4173-4. Epub 2014 Nov 17.

Memorial Sloan-Kettering Cancer Center, New York, NY

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.58.1678DOI Listing
December 2014

Acute pain relief after Mantram meditation in children with neuroblastoma undergoing anti-GD2 monoclonal antibody therapy.

J Pediatr Hematol Oncol 2014 Mar;36(2):152-5

*Department of Pediatrics †Office of Clinical Research, Memorial Sloan-Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000024DOI Listing
March 2014

Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.

Clin Cancer Res 2014 Mar 11;20(5):1375-82. Epub 2014 Feb 11.

Authors' Affiliations: Departments of Pediatrics and Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-1012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592799PMC
March 2014

Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.

Cancer 2013 Aug 30;119(15):2789-95. Epub 2013 Apr 30.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4326066PMC
August 2013

Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.

Cancer 2013 Feb 5;119(3):665-71. Epub 2012 Sep 5.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.27783
Publisher Site
http://dx.doi.org/10.1002/cncr.27783DOI Listing
February 2013

Emerging treatment options for the treatment of neuroblastoma: potential role of perifosine.

Onco Targets Ther 2012 2;5:21-9. Epub 2012 Mar 2.

Department of Pediatrics, Keck School of Medicine, University of Southern California, Children's Hospital of Los Angeles, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S14578DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299554PMC
October 2012

Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma.

Pediatr Blood Cancer 2012 Mar 17;58(3):469-71. Epub 2011 Mar 17.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.23132DOI Listing
March 2012

High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecan.

Pediatr Blood Cancer 2011 Mar;56(3):403-8

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22855DOI Listing
March 2011

Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.

J Clin Oncol 2011 Mar 22;29(9):1168-74. Epub 2011 Feb 22.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.28.3317DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083872PMC
March 2011

High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma.

Eur J Cancer 2011 Jan 8;47(1):84-9. Epub 2010 Oct 8.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2010.09.014DOI Listing
January 2011

Updates in the treatment of neuroblastoma.

Authors:
Shakeel Modak

Clin Adv Hematol Oncol 2011 Jan;9(1):74-6

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
January 2011

Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.

Int J Radiat Oncol Biol Phys 2010 Nov 6;78(3):849-54. Epub 2010 Mar 6.

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2009.09.005DOI Listing
November 2010

Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma.

Pediatr Blood Cancer 2010 Jul;55(1):76-80

Department of Pediatrics, New York Presbyterian-Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22452DOI Listing
July 2010

Neuroblastoma: Therapeutic strategies for a clinical enigma.

Cancer Treat Rev 2010 Jun 12;36(4):307-17. Epub 2010 Mar 12.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2010.02.006DOI Listing
June 2010

Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma.

Cancer 2010 Jun;116(12):3054-60

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25232DOI Listing
June 2010

A focal lesion in the falx cerebri: Harbinger of classic stage 4 neuroblastoma in an infant cured despite residual disease after minimal therapy.

Pediatr Blood Cancer 2009 Dec;53(7):1340-2

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22243DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079037PMC
December 2009

Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.

Int J Radiat Oncol Biol Phys 2009 Nov 8;75(4):1181-6. Epub 2009 May 8.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.12.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5587173PMC
November 2009

Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.

J Clin Oncol 2009 Mar 26;27(7):1041-6. Epub 2009 Jan 26.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.6107DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667809PMC
March 2009

Management and outcome of stage 3 neuroblastoma.

Eur J Cancer 2009 Jan 6;45(1):90-8. Epub 2008 Nov 6.

Department of Paediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2008.09.016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727624PMC
January 2009

Recurrent metastatic neuroblastoma followed by myelodysplastic syndrome: possible leukemogenic role of temozolomide.

Pediatr Blood Cancer 2008 Oct;51(4):552-4

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.21658
Publisher Site
http://dx.doi.org/10.1002/pbc.21658DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4010138PMC
October 2008

Solitary relapse of desmoplastic small round cell tumor detected by positron emission tomography/computed tomography.

J Clin Oncol 2008 Oct 22;26(30):4995-6. Epub 2008 Sep 22.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.9457DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652083PMC
October 2008

Brain-sparing radiotherapy for neuroblastoma skull metastases.

Pediatr Blood Cancer 2008 Jun;50(6):1163-8

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21384DOI Listing
June 2008

Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy.

Pediatr Blood Cancer 2008 Jun;50(6):1271-3

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.21391DOI Listing
June 2008

High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.

Pediatr Blood Cancer 2007 Apr;48(4):430-4

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20765DOI Listing
April 2007

Disialoganglioside directed immunotherapy of neuroblastoma.

Cancer Invest 2007 Feb;25(1):67-77

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357900601130763DOI Listing
February 2007

Whole-body clearance kinetics and external dosimetry of 131I-3F8 monoclonal antibody for radioimmunotherapy of neuroblastoma.

Health Phys 2007 Jan;92(1):33-9

Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.HP.0000231583.32904.6cDOI Listing
January 2007

Irinotecan plus temozolomide for relapsed or refractory neuroblastoma.

J Clin Oncol 2006 Nov;24(33):5271-6

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.06.7272DOI Listing
November 2006

Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.

Cancer 2006 Jul;107(2):417-22

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22004
Publisher Site
http://dx.doi.org/10.1002/cncr.22004DOI Listing
July 2006

Liver involvement in neuroblastoma: the Memorial Sloan-Kettering Experience supports treatment reduction in young patients.

Pediatr Blood Cancer 2006 Mar;46(3):278-84

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.20564
Publisher Site
http://dx.doi.org/10.1002/pbc.20564DOI Listing
March 2006

Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9.

Cancer Biother Radiopharm 2005 Oct;20(5):534-46

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/cbr.2005.20.534DOI Listing
October 2005

Long-term complications in survivors of advanced stage neuroblastoma.

Pediatr Blood Cancer 2005 Sep;45(3):324-32

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.20331DOI Listing
September 2005

Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan.

Leuk Res 2005 Jun;29(6):679-83

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2004.10.008DOI Listing
June 2005

Five-day courses of irinotecan as palliative therapy for patients with neuroblastoma.

Cancer 2005 Feb;103(4):858-62

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.20846DOI Listing
February 2005

Antibody-based targeted radiation to pediatric tumors.

J Nucl Med 2005 Jan;46 Suppl 1:157S-63S

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
January 2005

Results of multimodal treatment for desmoplastic small round cell tumors.

J Pediatr Surg 2005 Jan;40(1):251-5

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2004.09.046DOI Listing
January 2005

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.

J Clin Oncol 2004 Dec;22(24):4888-92

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2004.02.101
Publisher Site
http://dx.doi.org/10.1200/JCO.2004.02.101DOI Listing
December 2004

Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma.

Clin Cancer Res 2004 Jan;10(1 Pt 1):84-7

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
January 2004

Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience.

Med Pediatr Oncol 2003 Dec;41(6):508-15

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mpo.10273DOI Listing
December 2003

Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy.

Hybrid Hybridomics 2003 Aug;22(4):209-18

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/153685903322328938DOI Listing
August 2003

Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification.

Med Pediatr Oncol 2003 Jul;41(1):80-2

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/mpo.10287
Publisher Site
http://dx.doi.org/10.1002/mpo.10287DOI Listing
July 2003

Disialoganglioside GD2 and a novel tumor antigen: potential targets for immunotherapy of desmoplastic small round cell tumor.

Med Pediatr Oncol 2002 Dec;39(6):547-51

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. .

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mpo.10151DOI Listing
December 2002

Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteins.

Hybrid Hybridomics 2002 Dec;21(6):433-43

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/153685902321043963DOI Listing
December 2002

Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies.

Cancer Immunol Immunother 2002 Nov 20;51(10):557-64. Epub 2002 Sep 20.

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-002-0321-3DOI Listing
November 2002

Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.

Clin Cancer Res 2002 May;8(5):1217-23

Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
May 2002